Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 1/2008

01-02-2008 | Cancer Statistics

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

Authors: Kazuyuki Ishihara, Toshiaki Saida, Fujio Otsuka, Naoya Yamazaki, The Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society

Published in: International Journal of Clinical Oncology | Issue 1/2008

Login to get access
Metadata
Title
Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update
Authors
Kazuyuki Ishihara
Toshiaki Saida
Fujio Otsuka
Naoya Yamazaki
The Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society
Publication date
01-02-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 1/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0751-1

Other articles of this Issue 1/2008

International Journal of Clinical Oncology 1/2008 Go to the issue

Introduction to Review Articles

Current topics in breast cancer clinical research, 2007

Review Article

Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy

Review Article

No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan

Original Article

Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy

Original Article

Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer

Original Article

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits